The Lancet Regional Health. Western Pacific (Nov 2023)
Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
- Yanhua Li,
- Shitong Qiao,
- Lei Dong,
- Rong Zhang,
- Ruiqiang Li,
- Shijie Qin,
- Dongshan Yu,
- Xianfei Liu,
- Ying Li,
- Yueyun Ma,
- Xin Zhao,
- George Fu Gao
Affiliations
- Yanhua Li
- Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
- Shitong Qiao
- Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
- Lei Dong
- Department of Clinical Laboratory, Air Force Medical Center, Beijing, China
- Rong Zhang
- Guangxi University State Key Laboratory for Conservation and Utilization of Subtropical Agro BioResources, Nanning, China
- Ruiqiang Li
- Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences, Guangzhou, China
- Shijie Qin
- Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
- Dongshan Yu
- Department of Infectious Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, China
- Xianfei Liu
- Department of Clinical Laboratory, The Second Affiliated Hospital of Nanhua University, Hengyang, China
- Ying Li
- Department of Clinical Laboratory, Air Force Medical Center, Beijing, China
- Yueyun Ma
- Department of Clinical Laboratory, Air Force Medical Center, Beijing, China; Corresponding author.
- Xin Zhao
- Institute of Microbiology, Chinese Academy of Sciences, Beijing, China; Corresponding author.
- George Fu Gao
- Institute of Microbiology, Chinese Academy of Sciences, Beijing, China; Corresponding author.
- Journal volume & issue
-
Vol. 40
p. 100945
